Drug management.
- Published in:
- 2004
- Publication type:
- Journal Article
Works matching IS 10109609 AND DT 2004 AND VI 18 AND IP 4
Results: 55
1
2
The International Pharmacopoeia: monographs for tuberculosis medicines.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 320
- Publication type:
- Article
3
The International Pharmacopoeia: monographs for tuberculosis medicines.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 317
- Publication type:
- Article
4
The International Pharmacopoeia: monographs for tuberculosis medicines.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 313
- Publication type:
- Article
5
The International Pharmacopoeia: monographs for tuberculosis medicines.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 311
- Publication type:
- Article
6
The International Pharmacopoeia: monographs for tuberculosis medicines.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 308
- Publication type:
- Article
7
The International Pharmacopoeia: monographs for antiretrovirals.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 305
- Publication type:
- Article
8
The International Pharmacopoeia: monographs for antiretrovirals.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 302
- Publication type:
- Article
9
The International Pharmacopoeia -- monographs for antiretrovirals.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 299
- Publication type:
- Article
10
Medicinal plant guidelines translated.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 298
- Publication type:
- Article
11
Safety monitoring of herbal medicines.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 298
- Publication type:
- Article
12
International Pharmacopoeia available on CD-ROM.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 298
- Publication type:
- Article
13
Therapeutic guidelines: dermatology.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 297
- Publication type:
- Article
14
Procurement of medicines in HIV.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 297
- Publication type:
- Article
15
Evaluation of medicinal products in children.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 297
- Publication type:
- Article
16
New antimicrobial resistance website for the public.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 297
- Publication type:
- Article
17
COHRED and Research into Action.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 297
- Publication type:
- Article
18
New physician guidelines on commercial relationships.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 296
- Publication type:
- Article
19
International chemical reference substances for malaria.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 296
- Publication type:
- Article
20
New brochure on adverse reaction reporting.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 296
- Publication type:
- Article
21
Managing pharmaceuticals internationally.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 295
- Publication type:
- Article
22
International network on HIV/AIDS for pharmacists.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 295
- Publication type:
- Article
23
International Conference on Improving Use of Medicines.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 294
- Publication type:
- Article
24
WHO Medicines Bookshelf.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 294
- Publication type:
- Article
25
Three new quality assurance guidelines endorsed by WHO Expert Committee.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 294
- Publication type:
- Article
26
Combining TB and HIV treatment to save lives.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 293
- Publication type:
- Article
27
WHO Prequalification: implications of de-listing.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 291
- Publication type:
- Article
28
Urgent need for paediatric antiretroviral formulations.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 288
- Publication type:
- Article
29
3 by 5 strategy: improving access to paediatric HIV medicines.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 288
- Publication type:
- Article
30
Aripiprazole approved for acute bipolar mania.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 287
- Publication type:
- Article
31
Duloxetine approved for neuropathic pain associated with diabetes.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 286
- Publication type:
- Article
32
Long-term use of Depo-Provera® and bone density loss.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 286
- Publication type:
- Article
33
TNF-blocking agents and serious infections.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 286
- Publication type:
- Article
34
Mifepristone: labelling changes.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 285
- Publication type:
- Article
35
Epoetin alfa and blood clot formation in cancer patients.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 285
- Publication type:
- Article
36
Ephedrine and pseudoephedrine to become controlled drugs.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 284
- Publication type:
- Article
37
European regulation for paediatric medicinal products.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 284
- Publication type:
- Article
38
Southern hemisphere influenza vaccines 2005.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 283
- Publication type:
- Article
39
Regulations for COX-2 inhibitors.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 283
- Publication type:
- Article
40
Withdrawal of rofecoxib.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 282
- Publication type:
- Article
41
Antidepressants and suicidality in children and adolescents.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 281
- Publication type:
- Article
42
International standard for genetic testing.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 278
- Publication type:
- Article
43
National Library of Medicine trials registration.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 280
- Publication type:
- Article
44
Trials registration policy.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 279
- Publication type:
- Article
45
Selective reporting and clinical trial registration.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 278
- Publication type:
- Article
46
Medication error alert.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 277
- Publication type:
- Article
47
Infliximab and etanercept: serious infections and tuberculosis.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 275
- Publication type:
- Article
48
Transdermal fentanyl and respiratory arrest in adolescents.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 275
- Publication type:
- Article
49
Lamotrigine:hormonal contraceptives decrease serum levels.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 274
- Publication type:
- Article
50
Cholinesterase inhibitors and cardiac arrhythmias.
- Published in:
- WHO Drug Information, 2004, v. 18, n. 4, p. 273
- Publication type:
- Article